← Back to directory
C
Cambridge Innovation Capital
🇬🇧 UK-activeSeed VC·Cambridge, United Kingdom·5 partners Andrew Williamson +4·writes lead cheques
Invests at seed in ai-ml, b2b-saas. 2 rounds tracked.
Cheque range (GBP)
£1.0M – £10M
Typical: £1M–£10M (Series A focus; £600M AUM)
Last cheque
4mo ago
● actively deploying
Rounds (12mo)
7
none in last 90d
Tracked portfolio
2
since 2026
Recent investments
8 tracked rounds via funding databases| Company | Amount | When |
|---|---|---|
| Trent AI ↗ Provides AI-native security agents for autonomous systems | $13M | 4mo ago |
| BeyondMath ↗ Provides a generative physics AI model for engineering teams | $18.5M | 5mo ago |
T Therapeutics T cell receptor (TCR) therapeutics for cancer and autoimmune disease | 32.0M USD | 8mo ago |
Sortera Bio Deep screening platform to build AI models for drug discovery. | 10.0M USD | 1.1y ago |
Salience Labs Hybrid photonic-electronic chip designed for artificial intelligence applications. | — | 1.5y ago |
Forefront RF Fabless semiconductor manufacturer. | 20.7M USD | 1.7y ago |
Epitopea RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault. | 31.0M USD | 1.8y ago |
Unlikely AI Unlikely is a venture-backed start-up working on safe, trustworthy, and powerful artificial intelligence. | 20.0M USD | 3.9y ago |
Stages backed
Seed2 · 100%
Markets backed
Sectors & focus
Business models
Deep tech, Biotech, AI / ML
Other portfolio companies
24 from public sourcesImmutrinseries_a£65 mBack to insightsCMR Surgicalseries_b_plus$200MTRIMTECH Therapeuticseed$31MSalience Labseries_aCambridge GaN Deviceseries_b_plus$32MRiverlane£2.1mPragmatic Semiconductor£182mBiotechT-Therapeuticseries_a£48 mCongenicaVersiuComplement Therapeutic$79MSeldonseries_b_plus$20MCambridge Innovation£225MCambridge Innovation Capital£225 mMicrobiotica£50 mPetMedixseries_b_plus$37MCarrickOrigamiseries_b_plus£20 mCMR$600MSenseseries_b_plus$50mTrent Ai LimitedBeyondmath Limited
Frequent co-investors
From tracked deal dataWant a match-quality estimate?
Score your pitch and we'll tell you if Cambridge Innovation Capital matches your stage, sector, and cheque — before you ever email them.
Score my pitch →For Andrew & team at Cambridge Innovation Capital
This profile isn't claimed yet.
Claim it to correct your mandate, fix anything that's wrong, and start receiving UK founders who actually fit what you back.
Claim this profile →